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Endovascular repair of ruptured thoracic aortic
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Purpose:To analyze early and midterm results after endovascular treatment of ruptured thoracic aortic aneurysms (rTAA).
Methods:Between January 1997 and January 2009, a total of 236 patients received thoracic aortic repair in our institution;
23 patients (14 men; median age, 75 years; range, 60-88 years) due to a ruptured thoracic aortic aneurysm (rTAA).
Rupture was defined according to computed tomography angiograpy (CTA) criteria with definite sign for hemorrhage
outside the aortic wall. Patients with symptomatic TAA but with normal CT scans were excluded. A retrospective analysis
of these patients was performed. Median follow up was 28 months (range, 0.1-82.5 months) and included serial aortic
imaging at discharge, six, and 12 months and annually thereafter.
Results: Technical success rate was 87%. The overall in hospital mortality was 48% with predominantly (50%) cardiac
complications. Neurological complications occurred in three patients, two patients suffered from a transient ischemic attack
(TIA)/stroke, and one patient experienced paraplegia after early conversion to open surgery. Primary endoleaks were seen in
four of 25 patients (16%); no secondary endoleak was observed. Early conversion was necessary in two patients caused by an
aortoesophageal fistula. The one- and three-year survival rates were 37.3% and 29.9% with no aortic or procedure-related death
during follow up. Reintervention was necessary in four of 25 patients (16%). Cox regression analysis revealed preoperative
renal insufficiency (hazard ratio [HR] 5.85, P  .0073) as an independent predictor of perioperative death.
Conclusions: The endovascular treatment of ruptured thoracic aortic aneurysms is associated with a high perioperative
mortality and morbidity as well as poor midterm survival. Renal insufficency proved to be an independent risk factor for
perioperative death. (J Vasc Surg 2010;51:299-304.)Since its first description in 1998 by Dake et al, endo-
vascular treatment of thoracic aortic pathologies (TEVAR)
has become a first line treatment method in many cen-
ters.1-3 The potential benefits include minimal invasive
surgical access, avoidance of aortic cross clamping, and
single lung ventilation. An increasing number of studies
have thus reported a reduced morbidity and mortality for
TEVAR compared with open surgery in an elective set-
ting.4-7 Due to its minimal invasive character and fast
applicability, TEVAR seems especially appealing in emer-
gency situations. Large meta-analysis have recently proved
its benefit in selected patients with acute aortic transec-
tions.8-10 However, only a few data exist regarding the
results of emergency TEVAR procedures in ruptured ath-
erosclerotic thoracic aortic aneurysms.11-13
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doi:10.1016/j.jvs.2009.08.049The aim of this retrospective study was therefore to
review our experience in patients with ruptured thoracic
aortic aneurysms regarding perioperative mortality and
morbidity as well as midterm outcome.
METHODS
Patient population. Between January 1997 and Jan-
uary 2009, a total of 236 patients received thoracic aortic
repair in our institution, 23 patients (14 men; median age,
75 years; range, 60-88 years) due to a ruptured thoracic
aortic aneurysm (rTAA). Rupture was defined according to
computed tomography angiography (CTA) criteria that
included verification of contrast agent outside the aorta
and/or hemothorax. (Figs 1, 2). Patients with symptom-
atic TAAs but with normal CT scans, traumatic aortic
transections, ruptured penetrating aortic ulcers, or rup-
tured aortic dissections were excluded from this analysis. All
patients had a preoperative CT scan for procedure plan-
ning. After diagnosis/referral (defined as arrival of the
patient in our emergency room), the patients were imme-
diately transferred to the operation theatre and the median
time from referral to operation was 1.25 hours (range,
0.5-240 hours). One hemodynamic stable patient with a
contained ruptured TAA initially refused treatment but
returned from the referral hospital 10 days later with a
request for treatment and received immediate TEVAR.
To determine the preoperative hemodynamic status of
the patients, lowest preoperative hemoglobin level (mg/dL)
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rate  1) was used. The median preoperative hemoglobin
level was 9.9 (range, 6-14) and 30% of our patients showed a
positive shock index. In total, six patients were considered as
hemodynamic unstable, receiving preoperative inotropes and
volume therapy with blood transfusion.
For preoperative risk stratification, the logistic Euro-
Score and the American Society of Anesthesiologists (ASA)
classification was used. EuroScore is a preoperative risk
stratification system for cardiac and open thoracic aortic
surgery that includes demographic, cardiac related and
surgery related variables.14,15 Preoperative baseline charac-
teristics of our patients are given in Table I and show a
highly comorbid patient cohort with a median logEuroscore of
Fig 1. Preoperative computed tomography angiograp
centerline analysis (green line). TAA, Thoracic aortic an
Fig 2. Three-D volume rendering of the control com
rTAA with shrinkage of the aneurysm sack (white arrows)64 (range, 31-90).Preinterventional imaging. Stentgraft sizing was
based on preoperative contrast enhanced multislice CT an-
giography. For device selection, 15% oversizing was applied.
Anesthesiological management. Exclusion of the
ruptured aneurysm and avoidance of free rupture into the
pleural cavity is the first priority in treating rTAA. There-
fore, we tried to minimize preoperative volume therapy and
tolerate mean arterial blood pressures down to 60 mm Hg
(permissive hypotension). Additionally, we avoided preop-
erative mechanical ventilation with concomitant muscle
relaxation to maintain sympathetic-adrenergic stimulation
and preferred local anesthesia, if possible.
Follow up. Follow–up included postoperative CTA
before discharge, clinical examination, plain chest radiog-
hows a contained ruptured TAA (white arrow) with
m.
tomography angiographies show the exclusion of the
ng follow up. rTAA, Ruptured thoracic aortic aneurysm.hy sputedraphy, and CTA/MRA six and 12 months postoperatively
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(range, 0.1-82.5 months).
Definitions and statistical analysis. Technical suc-
cess in TEVAR procedures was defined according to
the reporting standards of endovascular procedures by
Chaikoff et al.13
Primary endoleaks were defined as present on intraop-
erative control angiography or first postoperative CTA
control, secondary endoleaks as appearance during follow
up. A retrospective analysis of the prospectively collected
data was performed. Data are expressed as median (range).
Survival analysis was calculated using the Kaplan Meier
analysis. Cox proportional hazard model (Cox regression
analysis) was used to identify independent preoperative risk
factors affecting survival. All statistical analysis were per-
formed using MedCalc (Version 9.5.2; MedCalc software,
Mariakerke, Belgium). A P value  .05 was defined statis-
tically significant.
RESULTS
Procedure. Twenty procedures (87%) were per-
formed under general anesthesia; three patients received
local anesthesia (Table II). Reasons for not using local
anesthesia were the necessity to use adenosine induced
cardiac arrest, respiratory or hemodynamic instability, non
compliance of the patient, or patient’s will.
The operation room is equipped with fluoroscopic and
angiographic capabilities (Series 9800; OEC Medical Sys-
tems, Inc, Salt Lake City, Utah until April 2007, after that
Axiom U, Siemens, Forchheim, Germany) and a carbon
fiber operating table. The procedure protocol has been
published before.3 Transfemoral surgical access was used in
16 (64%) patients. Six patients needed an iliac conduit graft
Table I. Baseline characteristics of all patients with rTAA
(n  23)
Age (yrs) 75 (60-88)
Gender (male) 14 (61)
ASA IIIIV 23 (100)
logEuroscore 64 (31-90)
Hypertension 23 (100)
History of smoking 19 (83)
CHD 19 (83)
Previous myocardial infarction 7 (30)
Renal insufficency 10 (43)
COPD 7 (30)
Diabetes 5 (22)
Previous aortic surgery 3 (13)
Lowest Hb preoperative (mg/dL) 9.9 (6-14)
Shock index 1 7 (30)
Hematothorax 17 (74)
Time referral – operation in hours 1.25 (0.5-240)
Hemodynamic instable 6 (26)
ASA, American Society of Anesthesiologists; CHD, coronary heart disease;
COPD, chronic obstructive pulmonary disease; Hb, hemoglobin; rTAA,
ruptured thoracic aortic aneurysm.
Values are presented as median (range) or n (%).
Shock index  systolic blood pressure/heart rate.due to small (8 mm) femoral access arteries. In onepatient, the right limb of a previously implanted aorto-
biiliac bifurcated prosthesis had to be used for stent graft
deployment. Extension of the proximal landing zone by
covering the left subclavian artery was performed in five
patients (22%). For exact positioning of the stentgraft in the
aortic arch, adenosine-induced cardiac arrest was used in
seven patients. During stent graft deployment, we experi-
enced proximal displacement of the prosthesis with unin-
tended coverage of the left carotid artery in one patient. An
immediate carotid-carotid cross-over bypass was per-
formed. The 85-year-old, highly comorbid patient died on
the first postoperative day of a multiorgan failure (renal
failure and pulmonary failure caused by a tracheomalacia as
a result of aneurysm compression) before CTA control or
neurological reevaluation could be performed. A total of 42
stentgrafts were implanted, with 14 patients (61%) receiv-
ing more than one stentgraft. Three types of devices were
implanted: 12x Talent/Valiant (Medtronic Vascular, Santa
Rosa, Calif), 9x TAG (W.L. Gore & Associates, Flagstaff,
Ariz), and 2x Zenith (Cook Inc, Bloomington, Ind).
Mortality and morbidity. Technical success was
achieved in 20/23 patients (87%), as three patients showed
relevant (type I or III) primary endoleaks (reinterventions;
see below).
The overall in hospital mortality was 48% (Table III).
Causes of death in these 11 patients were cardiac compli-
cations in seven patients, multiorgan failure in three, and
pulmonary embolism in one. Postoperative complications
occurred in 14 patients (61%), which included seven
patients with cardiac complications (five patients with peri-
operative myocardial infarction and two patients with he-
modynamic relevant arrhythmia). Six patients with preop-
erative impaired renal function showed an acute or chronic
renal failure and required postoperative hemodialysis. One
Table II. Procedure-specific data
Prosthesis
TAG 9 (39)
Talent/Valiant 12 (52)
Zenith 2 (9)
1 stent graft 14 (61)
Access site
Femoral 16 (70)
Iliac 6 (26)
Other 1 (4)
Anesthesia
Local 3 (13)
Spinal/epidural 0 (0)
GA 20 (87)
Adenosin-induced heart arrest 7 (30)
Operation time (min) 100 (60-253)
Proximal landing zone
Zone 0 2 (9)
Zone 1 1 (4)
Zone 2 2 (9)
Zone 3 13 (57)
Zone 4 5 (21)
GA, General anesthesia.
Values are presented as median (range) or n (%).patient experienced a groin wound infection and one pa-
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bleeding at the access site.
Neurological complications. One patient suffered
from an ischemic stroke with a left sided hemipareses on the
third postoperative day. Control CTA showed the stent
graft in the exact position with intended coverage of the left
subclavian artery. The actual cause remained unclear, but
the patient recovered completely and is currently, 6.8 years
after the operation, alive without further event. A second
patient showed a transient ischemic attack with aphasia and
right-sided hemipareses of unknown origin on the third
postoperative day. No residual neurological damage re-
mained.
No paraplegia was observed after TEVAR procedures,
but one patient showed a postoperative paraplegia after
requiring open conversion due to a de novo aorto-esophageal
fistula four weeks after stent graft repair (see below).
Primary endoleaks. Primary endoleaks were seen in
four of 25 patients (16%). Two patients showed a proximal
type I endoleak in the aortic arch at the first postoperative
CTA control. Reintervention with complete supraaortic
debranching and proximal stent graft extension, which
excluded the endoleak in both cases, was performed. One
patient had a type II endoleak via a retrograde perfused left
subclavian artery, which sealed spontaneously during fol-
low up. The fourth patient showed a small endoleak type
III at the overlapping zone of two stentgrafts in the first
postoperative control CTA. The patient died on the second
postoperative day due to a multiorgan failure before further
reintervention.
Early conversion. Early conversion was necessary in
two patients. One patient presented with an rTAA and an
additional aortoesophageal fistula. Initially, the patient re-
ceived an endovascular bridgingmanoeuver. Six days later a
staged, planned conversion using a silver Dacron prosthesis
was performed, but the patient died one month postoper-
Table III. Operative results
In hospital mortality 11 (48)
Perioperative morbidity 14 (61)
Stroke/TIA 2 (9)
Paraplegia 1 (4)
Cardiac complications 7 (36)
Respiratory failure 6 (26)
Renal failure 6 (26)
Groin wound infection 1 (4)
Bleeding 1 (4)
Open conversion
Early 2 (9)
Late 0 (0)
Primary endoleak 4 (17)
Type I 2 (9)
Type II 1 (4)
Type III 1 (4)
Late endoleak 0 (0)
Reintervention 4 (17)
TIA, Transient ischemic attack.
Values are presented as n (%).atively at the intensive care unit of a myocardial infarction.The second patient showed an aorto-esophageal fistula
after successful TEVAR for rTAA. The initial postoperative
course after TEVAR was uneventful. Three weeks postop-
eratively, the patient suddenly developed hematemesis with
signs of a new aorto-esophageal fistula in the CTA control.
Immediate conversion using distal perfusion via an axillo-
femoral bypass graft and additional resection of the esoph-
agus was performed. The intraoperative course was un-
eventful but the patient developed a paraplegia, which
persisted despite cerebrospinal fluid drainage. The patient is
currently three months postoperatively alive.
Risk factor analysis. Cox regression analysis revealed
renal insufficiency (HR 5.85, P  .007) as independent
predictor of perioperative death. A hemodynamic unstable
status (HR 3.12, P .091), chronic obstructive pulmonary
disease (COPD; HR 1.23, P  .751), and coronary heart
disease did not influence perioperative outcome (Table IV).
Midterm results. The actuarial survival estimates at
one and three years were 37.3% and 29.9% (Fig 3).
The causes of late death were cardiac failure during
coronary artery bypass grafting with aortic valve replace-
ment in one patient, lung cancer in one patient, and pneu-
monia in a 76-year-old patient three and a half years post-
operatively. There was no aortic related death during follow
Fig 3. Kaplan-Meier estimate of actuarial survival (including 95%
CI) in all patients (n  23) treated with TEVAR for rTAA. CI,
Confidence interval; rTAA, ruptured thoracic aortic aneurysm;
TEVAR, thoracic endovascular aortic repair.
Table IV. Risk factor analysis regarding perioperative
death
Variable Hazard ratio 95% CI P value
Renal insufficiency 5.85 1.617-21.153 .0073
COPD 1.23 0.331-4.639 .7511
CHD 0.39 0.092-1.725 .2211
Hemodynamic status 3.12 0.837-11.631 .0916
CHD, Coronary heart disease; COPD, chronic obstructive pulmonary dis-
ease.up. No late endoleak was observed.
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patients (16%). These patients have already been discussed
above.
DISCUSSION
The present series underlines the technical feasibility of
TEVAR in an emergency setting with patients presenting
with ruptured TAAs. Furthermore, it shows a high, non-
procedure related, perioperative mortality and morbidity
rate combined with poor midterm survival. Risk factor
analysis revealed renal insufficiency as an independent pre-
dictor of perioperative death. There was a tendency towards
a worse perioperative outcome in hemodynamic unstable
patients (HR 3.12; P  .091), which did just not reach
statistical significance in risk factor analysis, likely caused by
the small patient cohort (only six of 23 patients considered
hemodynamic unstable). To our knowledge, no other se-
ries exist focusing on risk factor analysis regarding endovas-
cular treatment of rTAA.
Mortality rates after TEVAR for acute descending aor-
tic rupture vary between 0% and 17% in the few available
series, which seems relatively low compared with our in-
hospital mortality rate of 48%11,12,16 This might be expli-
cable as all these series contain a variety of aortic patholo-
gies (rTAA, ruptured penetrating aortic ulcers, ruptured
acute aortic dissections, and traumatic aortic transections).
These entities all vary in outcome, pathology and proce-
dure-specific complications and should therefore not be
compared with this series. Especially the large proportion
of patients with traumatic transection (15%-68%) in these
studies, which have been excluded in our analysis, warrants
consideration as these patients are usually young, “healthy”
trauma victims and show favorable mortality and morbidity
rates after TEVAR as proved in various single center series
and meta analysis.8-10 In opposition to that, this series
represents a rather old (median age, 75 years), highly
comorbid (83% patients with coronary heart disease, 43%
patients with renal insufficiency, and 30% patients with
COPD) patient cohort, resulting in high cardio-pulmonary
and renal complications with consecutive perioperative
death. Midterm survival is influenced by these parameters.
Therefore, our three-year survival estimate of 30% is not
comparable to the only other reported midterm survival of
68% after two years by Morishita et al.16
In our series, two patients (9%) experienced a postop-
erative stroke or transient ischemic attack (TIA), which is in
line with Scheinert et al, who report a stroke rate of 9.5% in
their series of 21 patients with acute rupture of the descend-
ing aorta.13 Although the cause in our two patients re-
mained unclear, procedure associated factors, like emboli-
zation due to wire or nose cone manipulation in the aortic
arch could be possible explanations, but seem unlikely since
both events occurred on the third postoperative day. In our
series, no patient experienced paraplegia after TEVAR,
which is in line with the few reported literature on descend-
ing aortic rupture and is most likely due to the small
amount of patients in all series.13,17 Paraplegia after
TEVAR in elective cases can be expected in 1%-3% of allcases, with coverage of the left subclavian artery and previ-
ous aortic surgery as independent predictors.18,19
Small access vessel diameters caused by shock and/or
heavily calcified femoral or iliac arteries can make TEVAR
in patients with rTAA technically challenging procedures.
In this series, only 70% of all patients could be managed
with a femoral cut down, which emphasizes adequate pre-
operative access planning to avoid potentially lethal, unnec-
essary time delay during the operation. Although stentgraft
application was possible in all cases, technical success could
only be achieved in 87% of our patients as three patients
showed type I or III endoleaks. Both patients with proxi-
mal type I endoleak underwent complete arch debranching
to extend the proximal landing zone and received success-
ful proximal stent graft extension sealing the endoleak. In
retrospective analysis, both patients showed a very short
(approx. 1 cm) proximal landing zone, which was chosen as
a compromise to avoid sternotomy with complete de-
branching and thereby minimizing operative trauma in the
emergency setting. In general, one would aim for a proxi-
mal landing zone  2 cm and deliberately cover the left
subclavian artery (LSA, 22% in this series) to achieve a
sufficient sealing zone and perform staged revascularization
of the LSA if necessary (none in this series). Whether
primary revascularization or secondary transposition after
the development of symptoms in order to avoid type II
endoleaks and to reduce the risk of paraplegia is advocated
still remains debatable.18,20,21
Limitations. Limitations of this study certainly in-
clude the relatively small amount of patients and its retro-
spective design. However, only a few patients with rup-
tured thoracic aortic aneurysms reach the hospital alive and
this represents, to our knowledge, the largest single center
study population.
CONCLUSIONS
The endovascular treatment of ruptured thoracic aortic
aneurysms is associated with a high perioperative mortality
and morbidity as well as poor midterm survival. Renal
insufficency proved as an independend risk factor for peri-
operative death.
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